Clinical Trial

Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to to evaluate the effectiveness of Ultrapulse for the treatment of androgenic alopecia among Malaysian. The main questions it aims to answer are: * the efficacy of Ultrapulse in treatment of androgenic alopecia among Malaysian * the safety and adverse effect of Ultrapulse treatment. * the quality of life of androgenic alopecia among Malaysian.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-27; most recent amendment 2024-12-17.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-12-17
Trial Details
NCT Number NCT06292533
Lead Sponsor Universiti Tunku Abdul Rahman
Conditions Androgenic Alopecia, Alopecia
Enrollment 92 participants
Start Date 2024-12-01
Primary Completion 2025-08 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-18